Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Neurocrine Biosciences, Inc. (NBIX)

« Back to company index

NBIX Chatter Timeline

Stock Ticker for NBIX

Most Active Tweeters for NBIX

UserTweets
@bibeypost_stock 9
@whatsonthorold2 7
@reurope_stock 5
@AmericanBanking 5
@mmahotstuff1 4

Recent Tweets for NBIX

bibeypost_stock @bibeypost_stock
Baker Bros Advisors LP Stake in Neurocrine Biosciences INC $NBIX Has Trimmed by $4.92 Million - https://t.co/WLxW7s1Ug6
July 19th 2018, 12:07pm
mmahotstuff1 @mmahotstuff1
Neurocrine Biosciences INC $NBIX Shareholder Baker Bros Advisors LP Has Cut Holding - https://t.co/nPtuSYg0mu
July 19th 2018, 12:07pm
whatsonthorold2 @whatsonthorold2
Neurocrine Biosciences INC $NBIX Stock Rose While Baker Bros Advisors LP Cut by $4.92 Million Its Position - https://t.co/n6JuMa5cAl
July 19th 2018, 12:07pm
Fanob_stock @Fanob_stock
Baker Bros Advisors LP Has Decreased Neurocrine Biosciences INC $NBIX Holding by $4.92 Million; Shares Rose https://t.co/H92uBksHHb
July 19th 2018, 12:07pm
ConsumerFeed @ConsumerFeed
Neurocrine Biosciences $NBIX Price Target Raised to $127.00 https://t.co/zAkdMYXJmB
July 19th 2018, 5:07am
ConsumerFeed @ConsumerFeed
Critical Review: Mateon Therapeutics $MATN versus Neurocrine Biosciences $NBIX https://t.co/Poqrkrk81v
July 19th 2018, 5:07am
TranscriptDaily @TranscriptDaily
Head to Head Review: Neurocrine Biosciences $NBIX vs. BIO-TECHNE $TECH https://t.co/FbgI7i5LR6
July 19th 2018, 4:07am
bibeypost_stock @bibeypost_stock
Neurocrine Biosciences, Inc. $NBIX Analysts See $-0.18 EPS - https://t.co/dcACm5GiVp
July 18th 2018, 6:07pm
mmahotstuff1 @mmahotstuff1
Neurocrine Biosciences, Inc. $NBIX EPS Estimated At $-0.18 - https://t.co/0GwLYA1RnZ
July 18th 2018, 6:07pm
whatsonthorold2 @whatsonthorold2
Analysts See $-0.18 EPS for Neurocrine Biosciences, Inc. $NBIX - https://t.co/TxgRK9mZOS
July 18th 2018, 6:07pm
Fanob_stock @Fanob_stock
Neurocrine Biosciences, Inc. $NBIX EPS Estimated At $-0.18 https://t.co/y3ojE3aQ3j
July 18th 2018, 6:07pm
ThisLincolnian @ThisLincolnian
$84.57 Million in Sales Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/HchdF8YCxO
July 18th 2018, 5:07pm
WeekHerald @WeekHerald
-$0.18 Earnings Per Share Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/Huj09MpzDo
July 18th 2018, 5:07pm
EnterpriseLeade @EnterpriseLeade
Neurocrine Biosciences $NBIX PT Raised to $127.00 https://t.co/s3ODFsRgmg
July 18th 2018, 9:07am
dispatchtribune @dispatchtribune
JPMorgan Chase & Co. Boosts Neurocrine Biosciences $NBIX Price Target to $127.00 https://t.co/bGbfly0tdE
July 18th 2018, 4:07am
TheMarketsDaily @TheMarketsDaily
Contrasting Neurocrine Biosciences $NBIX and Ablynx $ABLYF https://t.co/LVrOEhYVOQ
July 18th 2018, 2:07am
dakotafinancial @dakotafinancial
Financial Analysis: Neurocrine Biosciences $NBIX vs. Ablynx $ABLYF https://t.co/MrWZssvQbJ
July 18th 2018, 2:07am
stockmktgenius @stockmktgenius
$NBIX Neurocrine Biosciences, I Top stock up 126% from low. Close: 104.54 VolvsAvg: 1.28 Liq: $63M https://t.co/6jzf5Y2Zcy
July 17th 2018, 8:07pm
bibeypost_stock @bibeypost_stock
Neurocrine Biosciences INC $NBIX Shareholder Rock Springs Capital Management LP Boosted Its Position - https://t.co/6H1az1UG0H
July 17th 2018, 1:07pm
reurope_stock @reurope_stock
Rock Springs Capital Management LP Has Increased Neurocrine Biosciences INC $NBIX Stake https://t.co/CMIGx3V7gw
July 17th 2018, 1:07pm
ZolmaxNews @ZolmaxNews
Neurocrine Biosciences $NBIX Price Target Increased to $127.00 by Analysts at JPMorgan Chase & Co. https://t.co/dNX4mU21pX
July 17th 2018, 7:07am
MareaInformativ @MareaInformativ
Comparing Mateon Therapeutics $MATN & Neurocrine Biosciences $NBIX https://t.co/MOYtrzCvWY
July 17th 2018, 6:07am
ChartMill @ChartMill
Besides having an excellent technical rating, $NBIX also presents a decent setup pattern. https://t.co/ziJf9p001c https://t.co/wKyj1H3fmE
July 16th 2018, 11:07am
EnterpriseLeade @EnterpriseLeade
-$0.18 EPS Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/3QE2e978qR
July 16th 2018, 11:07am
WeekHerald @WeekHerald
Analysts Anticipate Neurocrine Biosciences, Inc. $NBIX Will Announce Quarterly Sales of $84.57 Million https://t.co/w5kVXaAxhF
July 16th 2018, 10:07am
OlympiaReport @OlympiaReport
$84.57 Million in Sales Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/OQ3iu1T6Cw
July 16th 2018, 9:07am
dispatchtribune @dispatchtribune
Analysts Anticipate Neurocrine Biosciences, Inc. $NBIX to Post -$0.18 EPS https://t.co/fVjnQTBohp
July 16th 2018, 9:07am
TheMarketsDaily @TheMarketsDaily
Neurocrine Biosciences $NBIX and BIO-TECHNE $TECH Financial Comparison https://t.co/ZinPMDbbLD
July 16th 2018, 2:07am
AmericanBanking @AmericanBanking
Head to Head Survey: Neurocrine Biosciences $NBIX and Ablynx $ABLYF https://t.co/8bCxVU0Jy7 #stocks
July 15th 2018, 5:07am
TickerReport @TickerReport
Neurocrine Biosciences, Inc. $NBIX Expected to Post Earnings of -$0.18 Per Share https://t.co/LQ6MFMMAAd
July 15th 2018, 4:07am
WatchlistN @WatchlistN
Zacks: Brokerages Expect Neurocrine Biosciences, Inc. $NBIX Will Announce Earnings of -$0.18 Per Share https://t.co/XmylcPDEKc
July 15th 2018, 4:07am
AmericanBanking @AmericanBanking
Analyzing Mateon Therapeutics $MATN & Neurocrine Biosciences $NBIX https://t.co/x8BGOY4xu9 #stocks
July 14th 2018, 9:07pm
dakotafinancial @dakotafinancial
Analyzing Mateon Therapeutics $MATN & Neurocrine Biosciences $NBIX https://t.co/MjrVBWr00S
July 14th 2018, 9:07pm
ledgerzette @ledgerzette
Comparing Mateon Therapeutics $MATN and Neurocrine Biosciences $NBIX https://t.co/Gco58mVooi
July 14th 2018, 9:07pm
stockmktgenius @stockmktgenius
$NBIX Neurocrine Biosciences, I Top stock up 126% from low. Close: 102.89 VolvsAvg: 0.58 Liq: $27M https://t.co/6jzf5Y2Zcy
July 13th 2018, 6:07pm
stockmktgenius @stockmktgenius
$NBIX Neurocrine Biosciences, I Leading stock #BreakOutWatch Recent close 102.89 Liquidity: $27M https://t.co/6jzf5Y2Zcy
July 13th 2018, 6:07pm
MareaInformativ @MareaInformativ
$84.57 Million in Sales Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/ycpeyp0MEM
July 13th 2018, 6:07am
AmericanBanking @AmericanBanking
$84.57 Million in Sales Expected for Neurocrine Biosciences, Inc. $NBIX This Quarter https://t.co/dHMhxwrKR3 #stocks
July 13th 2018, 3:07am
bibeypost_stock @bibeypost_stock
Neurocrine Biosciences INC $NBIX Shareholder Bb Biotech Ag Has Lowered Its Position - https://t.co/aQxYkSAn6c
July 12th 2018, 4:07pm
reurope_stock @reurope_stock
Bb Biotech Ag Decreased Its Neurocrine Biosciences INC $NBIX Stake by $4.10 Million; Share Value Rose https://t.co/Zx0CGC0gtQ
July 12th 2018, 4:07pm
mmahotstuff1 @mmahotstuff1
Neurocrine Biosciences INC $NBIX Holder Bb Biotech Ag Trimmed Stake by $4.10 Million - https://t.co/F0BhYrQpzK
July 12th 2018, 4:07pm
whatsonthorold2 @whatsonthorold2
As Neurocrine Biosciences INC $NBIX Market Valuation Rose, Holder Bb Biotech Ag Cut by $4.10 Million Its Position - https://t.co/nEc7fzPdD2
July 12th 2018, 4:07pm
TickerReport @TickerReport
Analysts Set Neurocrine Biosciences, Inc. $NBIX Price Target at $102.77 https://t.co/FvdEbRpi2k
July 12th 2018, 1:07pm
WatchlistN @WatchlistN
Brokerages Set Neurocrine Biosciences, Inc. $NBIX Target Price at $102.77 https://t.co/evOb5TnRH5
July 12th 2018, 1:07pm
bibeypost_stock @bibeypost_stock
Neurocrine Biosciences, Inc. $NBIX Analysts See $-0.18 EPS - https://t.co/uDKxPPAfhk
July 11th 2018, 11:07pm
reurope_stock @reurope_stock
Neurocrine Biosciences, Inc. $NBIX EPS Estimated At $-0.18 https://t.co/M9uXvyu1K2
July 11th 2018, 11:07pm
The_CasualSmart @The_CasualSmart
EPS for Neurocrine Biosciences, Inc. $NBIX Expected At $-0.18 https://t.co/jvXA7NZ35F
July 11th 2018, 11:07pm
mmahotstuff1 @mmahotstuff1
Neurocrine Biosciences, Inc. $NBIX EPS Estimated At $-0.18 - https://t.co/fBB1hqjQAP
July 11th 2018, 11:07pm
whatsonthorold2 @whatsonthorold2
Neurocrine Biosciences, Inc. $NBIX Analysts See $-0.18 EPS - https://t.co/Pd9vMYh1MR
July 11th 2018, 11:07pm
The_CasualSmart @The_CasualSmart
Neurocrine Biosciences, Inc. $NBIX EPS Estimated At $-0.18 https://t.co/As6BQsaYZS
July 11th 2018, 11:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.